MEI Pharma Secures $100 Million Investment Led by GSR for Litecoin Treasury Asset

GSR, a prominent venture capital firm, has led a $100 million private investment in public equity (PIPE) into MEI Pharma, a Nasdaq-listed biotechnology company. This significant investment is aimed at establishing Litecoin as a treasury asset, marking a notable step towards the institutionalization of cryptocurrencies in traditional financial markets. GSR will collaborate closely with Charlie Lee, the creator of Litecoin, to implement this strategy. The investment includes participation from the Litecoin Foundation and several prominent crypto venture capital firms, underscoring the growing interest and confidence in Litecoin as a viable treasury asset.

The appointment of Charlie Lee to MEI Pharma's board and the designation of GSR as the treasury manager further solidify the strategic partnership. This move is expected to bring a new level of credibility and expertise to MEI Pharma's financial management, leveraging Lee's deep understanding of cryptocurrencies and GSR's extensive experience in venture capital. The investment is not only a financial boost for MEI Pharma but also a strategic move to integrate cryptocurrencies into the company's treasury management, potentially setting a precedent for other publicly listed companies.

The $100 million investment is a clear indication of the growing acceptance of cryptocurrencies in mainstream finance. By adopting Litecoin as a treasury asset, MEI Pharma is positioning itself at the forefront of this financial evolution. This move could inspire other companies to explore similar strategies, further integrating cryptocurrencies into traditional financial systems. The collaboration between GSR and Charlie Lee is expected to provide valuable insights and expertise, helping MEI Pharma navigate the complexities of cryptocurrency management and potentially unlock new opportunities for growth and innovation.

This initiative represents the first time a public company is aligning its treasury strategy with Litecoin at an institutional level. It reflects rising institutional confidence in LTC’s credibility, resilience, and regulatory clarity. There is already meaningful institutional interest in Litecoin, but few mechanisms exist to access it in a secure and structured way. This investment is designed to close that gap by enabling access to an asset with remarkable staying power.

With GSR as an investor, strategic advisor, and asset manager, the collaboration creates potential momentum for LTC’s future growth in decentralized finance. GSR’s broader involvement in the space, including the incubation of the Polygon-based protocol Katana, highlights its expertise in supporting emerging ecosystems. Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto venture capital firms and infrastructure providers, including Mozayyx, Parafi, HiveMind, Primitive, RLH Capital, Delta Blockchain, and CoinFund, among other financial institutions.

GSR continues to invest in the broader digital asset ecosystem, offering capital solutions, liquidity, and strategic advisory services to partners at all stages of growth. GSR is crypto’s capital markets partner, delivering market-making, institutional-grade OTC trading, and strategic venture backing to founders and institutions. With more than a decade of experience, GSR provides strategic guidance, market intelligence, and access to a global network to help teams scale.